The incidence of anaphylaxis following vaccination with Pfizer–BioNTech’s COVID-19 vaccine is slightly higher than that of schedule vaccines, so health professionals must be able to recognise this potentially fatal condition and differentiate it from immunisation stress-related responses, explain Marleen Hart, Aimee Brass and Shelley Kininmonth
Jilly Alexander of Ngā Kaitiaki o te Puna Rongoā – MPA describes a programme rolled out last year that proved effective in getting more Māori vaccinated against the flu, through outreach and whānau-centred engagement
Professor Peter McIntyre outlines key concepts for understanding what herd immunity does and does not mean, and what this can tell us about the new COVID-19 vaccines
Academic pharmacist Nataly Martini provides key information on Helicobacter pylori pathophysiology, diagnosis and evidence-based treatment strategies to enhance patient outcomes